Downers - Esmolol

Question 1

What is the typical push dose range for Esmolol?
(Select all that apply)

A. 1-2 mg
B. 5-10 mg
C. 10-20 mg
D. 15-25 mg

Answer 1

B. 5-10 mg

Question 2

What is the concentration of Esmolol that is typically used for dosing?
(Select all that apply)

A. 1 mg/mL
B. 5 mg/mL
C. 10 mg/mL
D. 20 mg/mL

Answer 2

C. 10 mg/mL

Concentration: 10 mg/mL, titrate to effect

Question 2

Which of the following describes the mechanism of action (MOA) of Esmolol?
(Select all that apply)

A. Selective Beta-1 blockade
B. Non-selective Beta blockade
C. Alpha-1 receptor antagonism
D. Selective Beta-2 blockade

Answer 2

A. Selective Beta-1 blockade

Question 3

What is the onset time of Esmolol when administered intravenously?
(Select all that apply)

A. 30 seconds
B. 1 minute
C. 5 minutes
D. 10 minutes

Answer 3

B. 1 minute

Question 4

What is the typical duration of action for Esmolol?
(Select all that apply)

A. 1 minute
B. 5 minutes
C. 10 minutes
D. 20 minutes

Answer 4

B. 5 minutes

Question 5

What is the half-life of Esmolol?
(Select all that apply)

A. 5 minutes
B. 9 minutes
C. 15 minutes
D. 30 minutes

Answer 5

B. 9 minutes

Question 6

How is Esmolol primarily eliminated from the body?
(Select all that apply)

A. Degradation by ester hydrolysis
B. Hepatic metabolism
C. Renal elimination of metabolites
D. Fecal excretion

Answer 6

A. Degradation by ester hydrolysis
C. Renal elimination of metabolites

Question 7

Which of the following side effects can be associated with Esmolol?
(Select all that apply)

A. Blunting of the physiological response to intubation
B. Increased seizure activity during electroconvulsive therapy (ECT)
C. Decreased seizure activity during electroconvulsive therapy (ECT)
D. Enhanced response to intubation

Answer 7

A. Blunting of the physiological response to intubation
C. Decreased seizure activity during electroconvulsive therapy (ECT)

Question 7

Which of the following situations is Esmolol particularly useful for managing?
(Select all that apply)

A. Supraventricular tachycardia (SVT)
B. Long-term management of chronic heart failure
C. Intraoperative tachycardia and hypertension
D. Prevention of postoperative infection

Answer 7

A. Supraventricular tachycardia (SVT)
C. Intraoperative tachycardia and hypertension

Action: SVT; intra-op tachycardia/HTN; ultra-short acting